Patents Assigned to Serimmune Inc.
  • Quality control reagents and methods for serum antibody profiling
    Patent number: 12297564
    Abstract: Disclosed herein are reagents for use in quality control assessment of antibody profiling platforms, such as biopanning and Digital Serology. Also disclosed herein are kits, method of manufacturing, and methods of using the same.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: May 13, 2025
    Assignee: Serimmune Inc.
    Inventors: Kathryn Vinaya Louise Kamath, Jack Ryan Reifert, Patrick Sean Daugherty
  • Methods and compositions for assessing antibody specificities
    Patent number: 12259396
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: June 14, 2024
    Date of Patent: March 25, 2025
    Assignee: Serimmune Inc.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert
  • Methods and compositions for assessing antibody specificities
    Patent number: 12146884
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: September 7, 2023
    Date of Patent: November 19, 2024
    Assignee: Serimmune Inc.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert
  • Methods and compositions for assessing antibody specificities
    Patent number: 11828762
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: November 28, 2023
    Assignee: Serimmune Inc.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert
  • Methods and compositions for assessing antibody specificities
    Patent number: 10871494
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: December 22, 2020
    Assignee: SERIMMUNE INC.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert
  • Methods and compositions for assessing antibody specificities
    Patent number: 10386373
    Abstract: The present invention provides compositions and methods that can be used to determine a peptide signature for an antibody repertoire in a sample comprising multiple antibodies. The method can be used to characterize a phenotype in a sample, such as providing a diagnosis, prognosis or theranosis of a medical condition.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: August 20, 2019
    Assignee: Serimmune Inc.
    Inventors: Patrick Sean Daugherty, Kathryn Vinaya Louise Kamath, Jack Ryan Reifert